PLIN2
Basic information
Region (hg38): 9:19108375-19149290
Previous symbols: [ "ADFP" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PLIN2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 33 | 36 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 33 | 1 | 2 |
Variants in PLIN2
This is a list of pathogenic ClinVar variants found in the PLIN2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-19116265-C-G | not specified | Uncertain significance (Dec 02, 2024) | ||
9-19116273-T-A | not specified | Uncertain significance (Dec 19, 2022) | ||
9-19116367-T-C | not specified | Uncertain significance (Apr 29, 2024) | ||
9-19116370-G-C | not specified | Uncertain significance (Oct 10, 2023) | ||
9-19116397-T-C | not specified | Uncertain significance (Mar 07, 2024) | ||
9-19116399-A-G | not specified | Uncertain significance (Aug 21, 2024) | ||
9-19116433-G-T | not specified | Uncertain significance (Dec 15, 2023) | ||
9-19116445-A-C | not specified | Uncertain significance (Oct 21, 2024) | ||
9-19116570-T-A | not specified | Uncertain significance (Mar 20, 2023) | ||
9-19116591-G-A | Benign (May 25, 2018) | |||
9-19116634-T-C | not specified | Uncertain significance (Jun 10, 2022) | ||
9-19116636-C-T | not specified | Uncertain significance (Sep 06, 2022) | ||
9-19118326-C-T | not specified | Uncertain significance (Jun 19, 2024) | ||
9-19118355-C-T | not specified | Uncertain significance (Jan 24, 2024) | ||
9-19118389-A-G | not specified | Uncertain significance (Sep 17, 2021) | ||
9-19118394-T-G | not specified | Uncertain significance (Aug 21, 2024) | ||
9-19118425-C-G | not specified | Uncertain significance (Sep 26, 2023) | ||
9-19118438-C-A | not specified | Uncertain significance (Oct 29, 2024) | ||
9-19118449-A-G | not specified | Uncertain significance (Feb 28, 2023) | ||
9-19119663-G-A | not specified | Uncertain significance (Sep 30, 2024) | ||
9-19119699-T-C | not specified | Uncertain significance (Mar 22, 2022) | ||
9-19119771-C-T | not specified | Uncertain significance (Dec 01, 2022) | ||
9-19119783-C-G | not specified | Uncertain significance (Dec 14, 2021) | ||
9-19119787-G-C | not specified | Uncertain significance (Feb 15, 2023) | ||
9-19119801-T-A | not specified | Uncertain significance (Jan 09, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PLIN2 | protein_coding | protein_coding | ENST00000276914 | 7 | 40916 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
7.53e-9 | 0.274 | 125703 | 0 | 45 | 125748 | 0.000179 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.956 | 285 | 243 | 1.17 | 0.0000128 | 2869 |
Missense in Polyphen | 51 | 45.953 | 1.1098 | 629 | ||
Synonymous | 0.884 | 84 | 95.0 | 0.885 | 0.00000532 | 861 |
Loss of Function | 0.618 | 14 | 16.7 | 0.837 | 7.07e-7 | 212 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000331 | 0.000329 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000381 | 0.000381 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000201 | 0.000193 |
Middle Eastern | 0.000381 | 0.000381 |
South Asian | 0.000199 | 0.000196 |
Other | 0.000181 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: May be involved in development and maintenance of adipose tissue. {ECO:0000250}.;
- Pathway
- PPAR signaling pathway - Homo sapiens (human);Adipogenesis;Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha);HIF-1-alpha transcription factor network
(Consensus)
Recessive Scores
- pRec
- 0.488
Intolerance Scores
- loftool
- 0.880
- rvis_EVS
- 0.04
- rvis_percentile_EVS
- 57.31
Haploinsufficiency Scores
- pHI
- 0.224
- hipred
- N
- hipred_score
- 0.216
- ghis
- 0.410
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Plin2
- Phenotype
- endocrine/exocrine gland phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; immune system phenotype; homeostasis/metabolism phenotype; liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); reproductive system phenotype; vision/eye phenotype;
Gene ontology
- Biological process
- response to organic cyclic compound;long-chain fatty acid transport;regulation of lipid metabolic process;lipid storage;response to drug
- Cellular component
- extracellular region;nucleus;endoplasmic reticulum;lipid droplet;cytosol;plasma membrane
- Molecular function